skip to content

Cambridge Immunology Network

 
Read more at: Cambridge-led SARS-CoV-2 genomic surveillance consortium receives £12.2 million

Cambridge-led SARS-CoV-2 genomic surveillance consortium receives £12.2 million

16 November 2020

The COVID-19 Genomics UK (COG-UK) Consortium has been backed by the Department for Health and Social Care Testing Innovation Fund to expand whole genome sequencing of positive SARS-CoV-2 virus samples to map how COVID-19 spreads and evolves. The £12.2M funding will facilitate the genome sequencing capacity needed to meet...


Read more at: Why it takes guts to protect the brain against infection

Why it takes guts to protect the brain against infection

4 November 2020

The brain is uniquely protected against invading bacteria and viruses, but its defence mechanism has long remained a mystery. Now, a study in mice, confirmed in human samples, has shown that the brain has a surprising ally in its protection: the gut. Read the original article here>


Read more at: Tiny golden bullets could help tackle asbestos-related cancers

Tiny golden bullets could help tackle asbestos-related cancers

28 October 2020

Gold nanotubes – tiny hollow cylinders one thousandth the width of a human hair – could be used to treat mesothelioma, a type of cancer caused by exposure to asbestos, according to a team of researchers at the Universities of Cambridge and Leeds. Read the original article here>


Read more at: COVID-19: "We’re in it for the long haul."

COVID-19: "We’re in it for the long haul."

21 October 2020

In late 2019, a new institute opened on the Cambridge Biomedical Campus. Its timing could not have been better - as the COVID-19 pandemic sent Britain into lockdown several months later, the institute found itself at the heart of the University’s response to this unprecedented challenge. Read the original article here>


Read more at: Vice-Chancellor’s awards showcase impact and engagement during the pandemic

Vice-Chancellor’s awards showcase impact and engagement during the pandemic

6 October 2020

Academics, students and professional members of staff from across the University have been recognised in this year’s Vice-Chancellor’s Research Impact and Engagement Awards for their work in areas including COVID-19 testing, PPE production and online engagement. Read the original article here>


Read more at: Cambridge researcher named to Time 100 list of world's most influential people

Cambridge researcher named to Time 100 list of world's most influential people

23 September 2020

Professor Ravi Gupta has been named today as one of Time Magazine’s 100 Most Influential People of the Year , in recognition of his work to bring about the second-ever cure of a patient with HIV. In 2019, the case of ‘ The London Patient ’ made global headlines, as 40-year-old Adam Castillejo underwent a bone marrow...


Read more at: COVID-19: What to expect from a vaccine. By Professor Gordon Dougan

COVID-19: What to expect from a vaccine. By Professor Gordon Dougan

11 September 2020

One of the hottest topics around COVID-19 is the need for a vaccine for this new disease, which has had a huge impact on both human health and economies. The disease caught most people completely by surprise and shows no signs of disappearing naturally. In many ways the consideration of health and economics form the two...


Read more at: New model predicts oesophageal cancer eight years early for half of all patients

New model predicts oesophageal cancer eight years early for half of all patients

7 September 2020

DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis, suggests a study led by researchers at the University of Cambridge and EMBL’s European Bioinformatics Institute (EMBL...


Read more at: Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

2 September 2020

Point-of-care testing – in other words, testing patients as soon as they arrive at the hospital – is essential for enabling healthcare workers to rapidly diagnose patients and direct those who test positive for infection to dedicated wards. A recent study showed that SAMBA II, a new point-of-care PCR test for SARS-CoV-2...


Read more at: Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

28 August 2020

The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19. Read the original article here>